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Motohiko Satoh1, Yukitoshi Takemura1, Hironobu Hamada2, Yoshitaka Sekido3,4 and Shunichiro Kubota1*Abstract
Malignant mesothelioma is an asbestos-related fatal disease with no effective cure. We studied whether a green tea
polyphenol, epigallocathechin-3-gallate (EGCG), could induce cell death in five human mesothelioma cell lines. We
found that EGCG induced apoptosis in all five mesothelioma cell lines in a dose-dependent manner. We further
clarified the cell killing mechanism. EGCG induced reactive oxygen species (ROS), and impaired the mitochondrial
membrane potential. As treatment with ROS scavengers, catalase and tempol, significantly inhibited the EGCG-
induced apoptosis, ROS is considered to be responsible for the EGCG-induced apoptosis. Further, we found that
EGCG induced autophagy, and that when autophagy was suppressed by chloroquine, the EGCG-induced cell death
was enhanced. Taken together, these results suggest that EGCG has a great potential for the treatment of
mesothelioma by inducing apoptosis and autophagy.
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Malignant mesothelioma is an aggressive tumor associated
with asbestos exposure. The worldwide incidence of meso-
thelioma is expected to increase [1,2]. Although many
clinical treatments including surgery, radiotherapy and
chemotherapy have been reported, the prognosis of
patients remains poor [3,4].
We recently reported that treatment with a high dose
of ascorbic acid brought about the death of human
mesothelioma cells by inducing reactive oxygen species
(ROS), which leads to oxidative stress, and subsequently,
to cell death [5]. We hypothesized that epigallocatechin-
3-gallate (EGCG) may induce mesothelioma cell death
by inducing reactive oxygen species, because EGCG is
known to be involved in oxidative stress [6,7]. The
effects of EGCG on mesothelioma growth have not yet
been sufficiently studied. Only two papers reported by
the same group are available concerning the effects of
EGCG on mesothelioma cell death [8,9]. In one paper
Burlando et al. reported that EGCG induced cell death* Correspondence: kubota.s787@gmail.com
1Department of Life Sciences, Graduate School of Arts and Sciences, The
University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan
Full list of author information is available at the end of the article
© 2013 Satoh et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orvia H2O2-dependent T-type Ca
2+ channel opening [8].
Their data are not inconsistent with our hypothesis that
EGCG may induce mesothelioma cell death via oxidative
stress. Although we had no data concerning H2O2-
dependent T-type Ca2+ channel opening, we tested our
idea that EGCG might induce autophagy in the present
study.
The main source of ROS is in the mitochondria, which
play pivotal roles in cell survival and cell death such as
apoptosis and autophagy. Autophagy is a lysosomal deg-
radation process involved in a wide range of physio-
logical and pathological processes that is often induced
under conditions of oxidative stress that could lead to
cell death [10-13]. Autophagy has been implicated in
many diseases, including cancer [12], where it apparently
has dual roles, acting as both a tumor suppressor and as
a tumor survival or growth factor. Several reports have
suggested that inhibition of autophagy restores chemo-
sensitivity and augmentes tumor cell death [13-19]. The
inhibition of autophagy can be achieved by using chloro-
quine (CQ) in combination with chemotherapy or tar-
geted agents [20-22].
In the present study, we demonstrate that EGCG
induced the death of five human mesothelioma celltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cell death occurred via ROS production and a reduc-
tion in the mitochondrial membrane potential. More-
over, we found that EGCG induced autophagy, and
that the inhibition of autophagy by CQ enhanced the
EGCG-induced cell death.
Results
EGCG inhibits mesothelioma cell growth
We first investigated whether EGCG inhibited cell growth
using five human mesothelioma cell lines (EHMES-10,
EHMES-1, ACC-meso, Y-meso and MSTO-211H). The
mesothelioma cells were treated with EGCG for 24 h at
concentrations from 10 μM to 500 μM. EGCG reduced
the cell viability in a dose-dependent manner (Figure 1).
Differences in the sensitivity to EGCG were observed
among the five cell lines. The concentrations required to
inhibit the growth of the cells by 50% (IC50) values were
179, 29, 42, 128 and 35 μM for the EHMES-10, EHMES-1,
ACC-meso, Y-meso, and MSTO-211H cells, respectively.A
C
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Figure 1 Effect of EGCG on mesothelioma cell growth. The mesotheliom
of the cells was evaluated with cell counting kit assay. Values are expressed as
**P < 0.01, *P < 0.05.Signal transduction induced by EGCG
We next studied the signal transduction involved in
EGCG-induced mesothelioma cell growth inhibition. We
studied apoptosis-related signal transduction to elucidate
whether the EGCG-induced mesothelioma cell growth
inhibition was due to apoptosis. Using the TUNEL assay
we found that EGCG induced mesothelioma cell apop-
tosis in EHMES-10, EHMES-1, ACC-meso, and Y-meso
cells. As similar results (many TUNEL positive cells)
were obtained for all four of these cell lines, only the
data for the ACC-meso cells are shown in Figure 2A.
As caspase-3 activation and PARP cleavage are hallmark
of apoptosis, we next studied caspase-3 activation and
PARP cleavage using a Western blot analysis. As expected,
EGCG induced caspase-3 fragments in both EHMES-10
and EHMES-1cells (Figure 2B), and PARP cleavage in
both EHMES-10 and Y-meso cells (Figure 2C). As
phospho-JNK, phospho-p38 and phospho-p53 also play
pivotal roles in apoptotic signaling, we next studied
whether EGCG induced expression of phospho-JNK,B
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Figure 2 Effects of EGCG on apoptotic signaling pathway in mesothelioma cells. (A) TUNEL assay was performed (right panel). The left
panel shows DAPI staining. (B) Active fragments of casapase-3 were analyzed. (C) Cleaved PARP fragments were analyzed. (D) Expression levels of
phospho-JNK and phospho-p38 were analyzed. (E) Phospho-p53 expression levels were analyzed.
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EGCG increased the expression levels of phospho-JNK,
phospho-p38 and phospho-p53 in EHMES-10, Y-meso
and ACC-meso cells after 1–3 hr (Figure 2D and 2E). All
these data about signal transduction are consistent with
the idea that EGCG induces apoptosis in mesothelioma
cells.
Mesothelioma cells produce reactive oxygen species
(ROS) following EGCG treatment
We next studied the mechanism responsible for the
apoptosis induced by EGCG using EHMES-10 cells.Since EGCG has been demonstrated to be involved in
oxidative stress [6,7], we first analyzed the ROS produc-
tion inside the cells. To determine whether EGCG leads
to ROS production, experiment was performed using
APF (a ROS probe), which could detect ROS such as
•OH, ONOO- and OCl-. After the treatment with 500
μM of EGCG for 30 min, the fluorescence intensity was
examined in EGCG-treated cells (Figure 3A). The results
suggest that EGCG induced ROS production inside the
cells. Therefore, we focused on mitochondria where
ROS are produced. The EHMES-10 cells were treated
with EGCG (100, 250 and 500 μM) for 24 hr, and were
Figure 3 Effect of EGCG on intracellular and mitochondrial ROS production, and mitochondrial membrane potential in mesothelioma
cells. (A) Intracellular superoxide was analyzed using APF. (B) JC-1 fluorescence was analyzed. (C) Mitochondrial superoxide was analyzed
by MitoSOX.
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escence was analyzed by FACS. The number of cells with
conventional mitochondrial membrane potential (JC-1
red fluorescence) was decreased (91.88%, 59.12% and
14.26%, respectively), while that of cells with a low mito-
chondrial membrane potential (JC-1 green fluorescence)
was increased in a dose-dependent manner (5.58%,
35.96% and 82.7%, respectively) (Figure 3B). These
results suggest that EGCG decreased mitochondrial
membrane potential.
We next examined the production of superoxide in
mitochondria by a FACS analysis, using MitoSOX Red, a
mitochondrial superoxide indicator. EHMES-10 cells
were treated with EGCG concentrations of 100, 200 and
300 μM for 24 hr, and then, the cells were incubated
with MitoSOX Red for 15 min. The mean fluorescence
intensity of MitoSOX Red was increased in a dose-
dependent manner (Figure 3C). These data suggest that
EGCG led to the production of superoxide in the mito-
chondria of EHMES-10 cells.Catalase and tempol inhibit EGCG-induced cell death
We next studied whether the ROS production was re-
sponsible for the EGCG-induced EHMES-10 cell death
using the H2O2-scavenger catalase and superoxide-
scavenger tempol [23-26]. EHMES-10 cells were incubated
with EGCG alone, EGCG+catalase, or EGCG+tempol and
then, the viability of the cells was analyzed using a cell
counting kit. Catalase (0.1, 1 and 10 μg/ml) significantly
prevented the EGCG-induced cell death (Figure 4A).
Tempol (1mM) also significantly inhibited the cell death
induced by 200 μM EGCG or 300 μM EGCG (Figure 4B),
but not that induced by 50 μM or 100 μM EGCG. These
data suggest that H2O2 and superoxide are responsible for
the EGCG-induced EHMES-10 cell death.
EGCG induces autophagy, and the inhibition of
autophagy enhances EGCG-induced cell death
As both apoptosis and autophagy are triggered by com-
mon upstream signals [27,28], we examined whether
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Figure 4 Catalase and tempol restore the cell death induced by
EGCG. EHMES-10 cells were incubated with EGCG together with
catalase (A) or together with tempol (B). The viability was evaluated
using cell counting kit assay. Values are expressed as absorbance at




Figure 5 Effect of EGCG on autophagy and the effect of CQ on
cell death. (A and B) Western blot analysis was performed using
LC-3 specific antibody or GAPDH antibody. (C) Y-meso cells were
incubated with EGCG together with CQ. Cell viability was analyzed
using cell counting kit. Values are expressed as absorbance at 450
nm. The results are expressed as Mean ± S.D. (n=6). **P < 0.01.
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examined using a specific antibody against LC3 in a
Western blot analysis. ACC-meso, Y-meso and EHMES-
10 cells were treated with EGCG (50, 250 and 200 μM,
respectively) for 3, 6, 9 and 12hr. Then, the expression
levels of LC3-I and LC3-II were analyzed. EGCG
increased the LC3-II expression levels at 3 and 6 hr
after treatment (Figure 5A and 5B). These data suggest
that EGCG induced autophagy in mesothelioma cells.
We further examined whether the inhibition of
autophagy affected the EGCG-induced cell death in
Y-meso cells. Y-meso cells were treated with chloro-
quine (CQ)(5 and 10 μM), an autophagy inhibitor and
with EGCG (100 and 150 μM) for 24 hr. Next, the cell
viability was analyzed using a cell counting kit. The
addition of chloroquine (CQ) at concentrations of 5and 10μM enhanced the EGCG (150 μM)-induced cell
death in a dose-dependent manner, but CQ did not
affect the cell death induced by 100 μM EGCG
(Figure 5C). These data indicate that the inhibition of
autophagy enhances EGCG-induced cell death.
Discussion
In this study, we demonstrated that EGCG induced
human mesothelioma cell death in a dose-dependent
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sible for such cell killing. EGCG induced reactive oxy-
gen species (ROS) and impaired the mitochondrial
membrane potential. The use of ROS scavengers, cata-
lase and tempol, significantly inhibited the EGCG-
induced apoptosis. Furthermore, we found that EGCG
induced autophagy, and that the suppression of
autophagy enhanced the EGCG-induced cell death.
There are many reports about the effects of EGCG on
cancer cell growth [7,29,30]. However, there are only
two papers concerning EGCG-induced mesothelioma
cell death [8,9]. In the former paper it was reported that
the EGCG-induced cell death occurred via H2O2-
dependent T-type Ca2+ channel opening. The data are
not inconsistent with our present data showing that
EGCG-induced mesothelioma cell death occurs via the
production of ROS (H2O2 and superoxide). As we did
not analyze the H2O2-dependent T-type Ca
2+ channel
opening, it is unclear whether H2O2-dependent T-type
Ca2+ channel opening is involved in our case.
As both apoptosis and autophagy are triggered by
common upstream signals [27,28], we tested whether
EGCG induced autophagy, and found that it did induce
autophagy, and that treatment of cells with CQ, an
autophagy inhibitor, augmented the EGCG-induced cell
death. Autophagy is known to play dual roles in cancer,
acting as both a tumor inhibitor and as a tumor growth
promoter [12]. In our present study, autophagy pro-
tected the mesothelioma cells from death. These data
are consistent with several reports in other cancer cells
demonstrated that the inhibition of autophagy restored
chemosensitivity and augmented tumor cell death
[13-19]. CQ is a well-known drug that is widely used for
the prophylaxis treatment of malaria because of both its
efficacy and low toxicity to humans [31-33]. It is also
widely used as an anti-rheumatoid agent [31], and our
data suggests that it may be useful for treating meso-
thelioma patients if used in combination with EGCG.
The cell death induced by EGCG was prevented by
treatment with catalase, thus suggesting that the effects
of EGCG were largely due to the production of hydro-
gen peroxide by the cells. Because the catalase was
added extracellularly, it could decrease the hydrogen
peroxide that was extracellularly induced by EGCG. In
contrast, tempol, a membrane-permeable radical scaven-
ger, also prevented the EGCG-induced cell death. This
reagent reduced the formation of the hydroxyl radical by
scavenging superoxide anions. These results suggest that
the superoxide anion produced in the cells could lead to
cell death either directly or indirectly. Therefore, EGCG
treatment may induce the disruption of the mitochon-
drial membrane potential inside cells. In fact, as shown
in Figure 3B, EGCG did decrease the mitochondrial
membrane potential.Several studies report that EGCG has dual function
of anti-oxidant and pro-oxidant potential [34,35]. Low
concentrations (i.e. 10 μM) of EGCG scavenged free
radicals thereby inhibiting oxidative damage to cellular
DNA. In contrast, higher concentrations (i.e. 100 μM) of
EGCG induced cellular DNA damage [34]. Dual function
of EGCG in normal human lymphocytes is reported in
[35]. In our present study we have shown similar results as
shown in Figure 1. In most mesothelioma cell lines higher
concentrations (i.e. 100 μM or 200 μM) of EGCG induced
cell death and low concentrations (i.e. 10 μM) of EGCG
failed to induce cell death.
The accumulating experimental evidence that cancer
cells are more susceptible to hydrogen peroxide and to
hydrogen peroxide-induced cell death than normal cells
was discussed in a mini-review paper [36]. However, it is
unclear what specific concentrations of hydrogen peroxide
are required to kill cancer cells. It has been speculated that
hydrogen peroxide may be present at low levels in normal
cells because there are higher levels of catalase activity.
Conclusion
We have herein shown that EGCG induced apoptosis
in five human mesothelioma cell lines. We further
demonstrated that the mechanism responsible for the
EGCG-induced cell death was via ROS production and
a decrease in the mitochondrial membrane potential.
Moreover, we found that EGCG induced autophagy,
and that the inhibition of autophagy by CQ enhanced
the EGCG-induced cell death. These data suggest that
EGCG may be useful for the treatment of malignant
mesothelioma. In vivo animal experiments using EGCG
in combination with CQ are currently underway in our
laboratory to confirm these effects and as a first step
toward the clinical application of this treatment.
Materials and methods
Cell culture and reagents
Five mesothelioma cell lines, ACC-meso 1 (ACC-meso)
[37], Y-meso 8A (Y-meso [37], EHMES-10 [38,39],
EHMES-1 [38], and MSTO-211H (purchased from ATCC,
Manassas, VA) were used in this study. ACC-meso and
Y-meso were cultured in DMEM (Dulbecco’s modified
Eagle’s medium) (Sigma, St. Louis, MO) supplemented
with 10% fetal calf serum and 1× penicillin–streptomycin
antibiotics (Wako Pure Chemical Industries Ltd., Osaka,
Japan). EHMES-10, EHMES-1 and MSTO-211H were
cultured in RPMI-1640 (Sigma) supplemented with 10%
fetal calf serum and 1×penicillin–streptomycin antibiotics.
All cell lines were incubated at 37°C in 5% CO2.
Cell viability assay
Cells were seeded at a density of 2,000 cells/well in
96-well plate and treated with EGCG at various con-
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ence of anti-oxidative agents, cells were treated with
EGCG (Sigma-Aldrich, Tokyo, Japan) or EGCG with
tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl)
(Sigma-Aldrich) or with EGCG and catalase (Sigma-
Aldrich) for 24 h. The cell viability was determined
using the Cell Counting Kit-8 (Dojindo Laboratories,
Kumamoto, Japan). The color intensity was measured in
a microplate reader (Thermo Electron Corporation,
Vantaa, Finland) at 450 nm.Western blotting analysis
After EGCG treatment, cells were lysed in Triton X-100
lysis buffer (1% Triton X-100, 10% glycerol, 150 mM
NaCl, 2 mM EDTA, 0.02% NaN3, 10 μg/ml PMSF, and
1 mM Na3VO4). Total cell lysates were separated by
SDS-PAGE and transferred to polyvinylidene difluoride
(PVDF) membranes. The membranes were reacted with
a rabbit anti-PARP (Poly ADP-ribose polymerase) anti-
body, anti-phosho-p53 (ser20) antibody, anti-phospho
JNK (c-Jun N-terminal protein kinase) antibody, anti-
phosho-p38 antibody, anti-actin antibody, and anti-
caspase-3 antibody (New England Biolabs, Ipswich,
MA) followed by a peroxidase-conjugated anti-rabbit
IgG antibody (New England Biolabs). In other expe-
riments, membranes were reacted with a mouse anti-
LC3 (microtubule associated protein 1 light chain-3)
monoclonal antibody (nanoTools, Teninge, Germany),
and an anti-GAPDH monoclonal antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) followed by a
peroxidase-conjugated anti-mouse IgG antibody (New
England Biolabs). Proteins were then visualized using
Immobilon Western reagents (Millipore, Billerica, MA).Mitochondrial membrane potential and superoxide
detection
J-aggregate-forming lipophilic cation (JC-1) (Wako Pure
Chemical Industries Ltd.) was used to evaluate the mito-
chondrial membrane potential. For these experiments,
EHMES-10 cells were seeded on 24-well plate. After
EGCG treatment for 24 h, the cells were washed with
PBS containing 10% fetal calf serum (10% FCS-PBS) and
incubated with 2 μg/ml JC-1 (final concentration) in 10%
FCS-PBS for 30 min at 37°C.
Intracellular superoxide was detected using 30-p-
(aminophenyl) fluorescein(APF)(SEKISUI MEDICAL
CO. LTD., Tokyo, Japan). EHMES-10 cells were seeded
on 12-well plate, and the cells were incubated with
5 μM APF (final concentration) for 30 min at 37°C.
After washing with medium, the cells were treated with
EGCG for 30min. Then, the cells were re-suspended in
500 μl of warm culture medium and analyzed by a FACS
Calibur instrument (BD, Franklin Lakes, NJ).Mitochondrial superoxide in living cells was detected
using MitoSOX (Invitrogen, Eugene, OR). EHMES-10
cells were incubated for 24 h. Then, the cells were
incubated with MitoSOX Red (final concentration
5 μg/ml) for 15 min at 37°C. After being washed with
warm culture medium, the cells were re-suspended in
500 μl of warm culture medium and analyzed by a FACS
Calibur instrument.
TUNEL assay
ACC-meso cells were seeded on LabTek chamber slides
(Nalge Nunc International, Rochester, NY) and incu-
bated with 100 μM EGCG for 16 h at 37°C. Then, the
cells were washed twice with PBS (phosphate–buffered
saline) and fixed with 3% formaldehyde in PBS for
30 min. The fixed cells were stained using the terminal
dUTP nick-end labeling (TUNEL) method, using an In
Situ Cell Death Detection Kit, TMR (Roche Applied
Science, Mannheim, Germany), according to the manu-
facturer’s instructions.
Statistical analysis
The results are expressed as the means±standard devi-
ation. The means were compared to those of untreated
control cells using Student’s t-test. One way ANOVA with
a Bonferroni multiple comparison post-hoc test was
performed when more than two groups were compared
using the Excel Statcel 3 software program (purchased
from the publisher OMS Ltd., Tokyo, Japan). A probability
value<0.05 was considered to be statistically significant.
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